483
Philips North AmericaPhilips North America – FDA 483, Dec 13, 2023
Record Details
An FDA inspection of Philips North America in Cambridge, MA, revealed significant deficiencies in their quality system, particularly concerning the Vital Plus Patient Monitoring System. The firm's procedures for complaint handling, corrective and preventive actions (CAPA), and control of nonconforming products were found to be inadequately established. These issues included missing documentation, unapproved extensions, and lack of adherence to internal procedural requirements.
View Company Profile
ID · 5d1fb101-85aa-4fbe-ac15-4e3e0c7ccedc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.